GKOS — GLAUKOS CORP

Ownership history in PFM Health Sciences, LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which PFM Health Sciences, LP reported a position in GLAUKOS CORP (GKOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.27% (2025 Q4)
Avg. % of fund
2.27%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 201,676 — — 2.27% $22.8M $112.91
% of Fund (quarterly)    GKOS price (monthly, adj. close)

Other funds also holding GKOS

As of 2025 Q4 — sorted by position size

BRAIDWELL LP 3Y 3.33% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 3.02% Rhenman & Partners Asset Management AB 3Y 7Y 2.22% Resolute Capital Asset Partners LLC 3Y 2.21% Integral Health Asset Management, LLC 3Y 1.82% Exome Asset Management LLC 1.7% Capricorn Fund Managers Ltd 3Y 1.63% Taylor Frigon Capital Management LLC 3Y 7Y 1.62% Sofinnova Investments, Inc. 3Y 7Y 1.4% RIVERBRIDGE PARTNERS LLC 3Y 7Y 1.13%
← Back to PFM Health Sciences, LP Holdings